News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA) Shifts Focus To Embrace Integration In Diabetes, Unveils Company's Ambition At Conference


6/18/2014 6:44:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The company has become a leader in the area over the past decade thanks to its insulin Lantus, but now Sanofi wants to move away from the idea of pushing drugs to developing a more integrated diabetes business led by collaboration.

Speaking at a press conference at the event, Sanofi's Pascale Witz, executive VP, global divisions and strategic development, explained that the company was keen to match its efforts in patient care to that of its R&D business, which has moved from an internal model to one that is now reliant on external partners to discover innovative products.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release

comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES